nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0124	0.109	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0105	0.0923	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00693	0.0608	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00652	0.0572	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00646	0.0567	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00492	0.0432	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00447	0.0392	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00391	0.0343	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00379	0.0332	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00354	0.0311	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00298	0.0262	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0027	0.0237	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00252	0.0222	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00242	0.0212	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00219	0.0192	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00206	0.018	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00206	0.018	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00184	0.0162	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00167	0.0146	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00157	0.0137	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00157	0.0137	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00156	0.0137	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00153	0.0134	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00149	0.0131	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00141	0.0124	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00138	0.0121	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00119	0.0105	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00107	0.00942	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000945	0.00829	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000941	0.00826	CbGpPWpGaD
Degarelix—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000905	0.00102	CcSEcCtD
Degarelix—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000904	0.00102	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000903	0.00793	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000903	0.00793	CbGpPWpGaD
Degarelix—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000902	0.00102	CcSEcCtD
Degarelix—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000902	0.00102	CcSEcCtD
Degarelix—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000896	0.00101	CcSEcCtD
Degarelix—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000893	0.00101	CcSEcCtD
Degarelix—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00089	0.001	CcSEcCtD
Degarelix—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00089	0.001	CcSEcCtD
Degarelix—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000889	0.001	CcSEcCtD
Degarelix—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000889	0.001	CcSEcCtD
Degarelix—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000886	0.001	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000885	0.00776	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000885	0.00776	CbGpPWpGaD
Degarelix—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000884	0.000998	CcSEcCtD
Degarelix—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000882	0.000995	CcSEcCtD
Degarelix—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000882	0.000995	CcSEcCtD
Degarelix—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000882	0.000995	CcSEcCtD
Degarelix—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00088	0.000993	CcSEcCtD
Degarelix—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000877	0.00099	CcSEcCtD
Degarelix—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000877	0.000989	CcSEcCtD
Degarelix—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000876	0.000989	CcSEcCtD
Degarelix—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000874	0.000986	CcSEcCtD
Degarelix—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000874	0.000986	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000874	0.000986	CcSEcCtD
Degarelix—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000872	0.000985	CcSEcCtD
Degarelix—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000869	0.000981	CcSEcCtD
Degarelix—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000869	0.000981	CcSEcCtD
Degarelix—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000868	0.00098	CcSEcCtD
Degarelix—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000867	0.000979	CcSEcCtD
Degarelix—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000867	0.000979	CcSEcCtD
Degarelix—Rash—Didanosine—acquired immunodeficiency syndrome	0.000862	0.000972	CcSEcCtD
Degarelix—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000861	0.000972	CcSEcCtD
Degarelix—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000861	0.000971	CcSEcCtD
Degarelix—Headache—Didanosine—acquired immunodeficiency syndrome	0.000856	0.000966	CcSEcCtD
Degarelix—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000855	0.000965	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000854	0.0075	CbGpPWpGaD
Degarelix—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000854	0.000964	CcSEcCtD
Degarelix—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000853	0.000962	CcSEcCtD
Degarelix—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000851	0.000961	CcSEcCtD
Degarelix—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00085	0.000959	CcSEcCtD
Degarelix—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000848	0.000957	CcSEcCtD
Degarelix—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000843	0.000952	CcSEcCtD
Degarelix—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000842	0.00095	CcSEcCtD
Degarelix—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000842	0.00095	CcSEcCtD
Degarelix—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000841	0.000949	CcSEcCtD
Degarelix—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000839	0.000947	CcSEcCtD
Degarelix—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000839	0.000946	CcSEcCtD
Degarelix—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000838	0.000946	CcSEcCtD
Degarelix—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000837	0.000944	CcSEcCtD
Degarelix—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000836	0.000944	CcSEcCtD
Degarelix—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000834	0.000941	CcSEcCtD
Degarelix—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000834	0.000941	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00083	0.000937	CcSEcCtD
Degarelix—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000828	0.000934	CcSEcCtD
Degarelix—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000827	0.000933	CcSEcCtD
Degarelix—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000827	0.000933	CcSEcCtD
Degarelix—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000826	0.000932	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000825	0.000932	CcSEcCtD
Degarelix—Pain—Indinavir—acquired immunodeficiency syndrome	0.00082	0.000925	CcSEcCtD
Degarelix—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00082	0.000925	CcSEcCtD
Degarelix—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000819	0.000925	CcSEcCtD
Degarelix—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000819	0.000924	CcSEcCtD
Degarelix—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000818	0.000923	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000817	0.00717	CbGpPWpGaD
Degarelix—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000816	0.000921	CcSEcCtD
Degarelix—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000815	0.00092	CcSEcCtD
Degarelix—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000815	0.00092	CcSEcCtD
Degarelix—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000814	0.000919	CcSEcCtD
Degarelix—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000813	0.000918	CcSEcCtD
Degarelix—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000812	0.000916	CcSEcCtD
Degarelix—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000812	0.000916	CcSEcCtD
Degarelix—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00081	0.000914	CcSEcCtD
Degarelix—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000808	0.000912	CcSEcCtD
Degarelix—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000805	0.000908	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000803	0.00705	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000803	0.00705	CbGpPWpGaD
Degarelix—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0008	0.000902	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000799	0.000902	CcSEcCtD
Degarelix—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000795	0.000897	CcSEcCtD
Degarelix—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00079	0.000892	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00079	0.000891	CcSEcCtD
Degarelix—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.000889	CcSEcCtD
Degarelix—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000787	0.000888	CcSEcCtD
Degarelix—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000787	0.000888	CcSEcCtD
Degarelix—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000786	0.000887	CcSEcCtD
Degarelix—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000784	0.000885	CcSEcCtD
Degarelix—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000784	0.000885	CcSEcCtD
Degarelix—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000784	0.000885	CcSEcCtD
Degarelix—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000782	0.000883	CcSEcCtD
Degarelix—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000781	0.000882	CcSEcCtD
Degarelix—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000781	0.000882	CcSEcCtD
Degarelix—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000779	0.000879	CcSEcCtD
Degarelix—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000775	0.000875	CcSEcCtD
Degarelix—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000775	0.000874	CcSEcCtD
Degarelix—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000775	0.000874	CcSEcCtD
Degarelix—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000775	0.000874	CcSEcCtD
Degarelix—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000774	0.000874	CcSEcCtD
Degarelix—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000773	0.000872	CcSEcCtD
Degarelix—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000773	0.000872	CcSEcCtD
Degarelix—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00077	0.000869	CcSEcCtD
Degarelix—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000768	0.000867	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000763	0.000861	CcSEcCtD
Degarelix—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000762	0.00086	CcSEcCtD
Degarelix—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000759	0.000856	CcSEcCtD
Degarelix—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000758	0.000856	CcSEcCtD
Degarelix—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000758	0.000856	CcSEcCtD
Degarelix—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000757	0.000854	CcSEcCtD
Degarelix—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000757	0.000854	CcSEcCtD
Degarelix—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000754	0.000851	CcSEcCtD
Degarelix—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.00085	CcSEcCtD
Degarelix—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000751	0.000848	CcSEcCtD
Degarelix—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00075	0.000847	CcSEcCtD
Degarelix—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00075	0.000846	CcSEcCtD
Degarelix—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000749	0.000846	CcSEcCtD
Degarelix—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000749	0.000845	CcSEcCtD
Degarelix—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000748	0.000845	CcSEcCtD
Degarelix—Rash—Stavudine—acquired immunodeficiency syndrome	0.000748	0.000844	CcSEcCtD
Degarelix—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000747	0.000843	CcSEcCtD
Degarelix—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000747	0.000843	CcSEcCtD
Degarelix—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000747	0.000843	CcSEcCtD
Degarelix—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000746	0.000842	CcSEcCtD
Degarelix—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000745	0.000841	CcSEcCtD
Degarelix—Headache—Stavudine—acquired immunodeficiency syndrome	0.000743	0.000839	CcSEcCtD
Degarelix—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000743	0.000839	CcSEcCtD
Degarelix—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000741	0.000837	CcSEcCtD
Degarelix—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000741	0.000837	CcSEcCtD
Degarelix—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000741	0.000836	CcSEcCtD
Degarelix—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00074	0.000835	CcSEcCtD
Degarelix—Rash—Abacavir—acquired immunodeficiency syndrome	0.000737	0.000832	CcSEcCtD
Degarelix—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000736	0.000831	CcSEcCtD
Degarelix—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000736	0.000831	CcSEcCtD
Degarelix—Headache—Abacavir—acquired immunodeficiency syndrome	0.000732	0.000826	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00073	0.000824	CcSEcCtD
Degarelix—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00073	0.000824	CcSEcCtD
Degarelix—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00073	0.000823	CcSEcCtD
Degarelix—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000725	0.000818	CcSEcCtD
Degarelix—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000722	0.000815	CcSEcCtD
Degarelix—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000721	0.000814	CcSEcCtD
Degarelix—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00072	0.000812	CcSEcCtD
Degarelix—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000716	0.000808	CcSEcCtD
Degarelix—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000716	0.000808	CcSEcCtD
Degarelix—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000715	0.000807	CcSEcCtD
Degarelix—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000715	0.000807	CcSEcCtD
Degarelix—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000714	0.000806	CcSEcCtD
Degarelix—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000712	0.000803	CcSEcCtD
Degarelix—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000709	0.0008	CcSEcCtD
Degarelix—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000707	0.000798	CcSEcCtD
Degarelix—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000707	0.000797	CcSEcCtD
Degarelix—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000705	0.000796	CcSEcCtD
Degarelix—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000705	0.000795	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000703	0.000793	CcSEcCtD
Degarelix—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000698	0.000788	CcSEcCtD
Degarelix—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.000786	CcSEcCtD
Degarelix—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000694	0.000783	CcSEcCtD
Degarelix—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000692	0.000781	CcSEcCtD
Degarelix—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000691	0.00078	CcSEcCtD
Degarelix—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000689	0.000777	CcSEcCtD
Degarelix—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000688	0.000776	CcSEcCtD
Degarelix—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000688	0.000776	CcSEcCtD
Degarelix—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000688	0.000776	CcSEcCtD
Degarelix—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000686	0.000774	CcSEcCtD
Degarelix—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000686	0.000774	CcSEcCtD
Degarelix—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000685	0.000773	CcSEcCtD
Degarelix—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000685	0.000773	CcSEcCtD
Degarelix—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000682	0.00077	CcSEcCtD
Degarelix—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000678	0.000766	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000673	0.00591	CbGpPWpGaD
Degarelix—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.000757	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000671	0.000757	CcSEcCtD
Degarelix—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000668	0.000753	CcSEcCtD
Degarelix—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000666	0.000752	CcSEcCtD
Degarelix—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000666	0.000751	CcSEcCtD
Degarelix—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000665	0.000751	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000663	0.00582	CbGpPWpGaD
Degarelix—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000661	0.000746	CcSEcCtD
Degarelix—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00066	0.000745	CcSEcCtD
Degarelix—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00066	0.000745	CcSEcCtD
Degarelix—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000656	0.000741	CcSEcCtD
Degarelix—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000656	0.00074	CcSEcCtD
Degarelix—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000656	0.00074	CcSEcCtD
Degarelix—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000656	0.00074	CcSEcCtD
Degarelix—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00065	0.000734	CcSEcCtD
Degarelix—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00065	0.000734	CcSEcCtD
Degarelix—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00065	0.000733	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000646	0.00567	CbGpPWpGaD
Degarelix—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000646	0.000729	CcSEcCtD
Degarelix—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000641	0.000723	CcSEcCtD
Degarelix—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00064	0.000722	CcSEcCtD
Degarelix—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000639	0.000721	CcSEcCtD
Degarelix—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000637	0.000719	CcSEcCtD
Degarelix—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000636	0.000718	CcSEcCtD
Degarelix—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000635	0.000717	CcSEcCtD
Degarelix—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000635	0.000716	CcSEcCtD
Degarelix—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000634	0.000716	CcSEcCtD
Degarelix—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000634	0.000715	CcSEcCtD
Degarelix—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000634	0.000715	CcSEcCtD
Degarelix—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000631	0.000712	CcSEcCtD
Degarelix—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000629	0.00071	CcSEcCtD
Degarelix—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000629	0.00071	CcSEcCtD
Degarelix—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000622	0.000702	CcSEcCtD
Degarelix—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00062	0.0007	CcSEcCtD
Degarelix—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000613	0.000692	CcSEcCtD
Degarelix—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000613	0.000692	CcSEcCtD
Degarelix—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000612	0.000691	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000611	0.00536	CbGpPWpGaD
Degarelix—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00061	0.000688	CcSEcCtD
Degarelix—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00061	0.000688	CcSEcCtD
Degarelix—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00061	0.000688	CcSEcCtD
Degarelix—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000607	0.000685	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000606	0.00532	CbGpPWpGaD
Degarelix—Rash—Indinavir—acquired immunodeficiency syndrome	0.000605	0.000682	CcSEcCtD
Degarelix—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000604	0.000682	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000602	0.00528	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000602	0.000679	CcSEcCtD
Degarelix—Headache—Indinavir—acquired immunodeficiency syndrome	0.000601	0.000678	CcSEcCtD
Degarelix—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000599	0.000676	CcSEcCtD
Degarelix—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000593	0.000669	CcSEcCtD
Degarelix—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000591	0.000667	CcSEcCtD
Degarelix—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000585	0.00066	CcSEcCtD
Degarelix—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000582	0.000657	CcSEcCtD
Degarelix—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000582	0.000657	CcSEcCtD
Degarelix—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000576	0.00065	CcSEcCtD
Degarelix—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000575	0.000649	CcSEcCtD
Degarelix—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000573	0.000647	CcSEcCtD
Degarelix—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000571	0.000645	CcSEcCtD
Degarelix—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000571	0.000644	CcSEcCtD
Degarelix—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00057	0.000643	CcSEcCtD
Degarelix—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000568	0.000642	CcSEcCtD
Degarelix—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000568	0.000641	CcSEcCtD
Degarelix—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000567	0.00064	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000558	0.0049	CbGpPWpGaD
Degarelix—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000554	0.000625	CcSEcCtD
Degarelix—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000551	0.000622	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000551	0.00483	CbGpPWpGaD
Degarelix—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000548	0.000619	CcSEcCtD
Degarelix—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000547	0.000617	CcSEcCtD
Degarelix—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000546	0.000616	CcSEcCtD
Degarelix—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000546	0.000616	CcSEcCtD
Degarelix—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000543	0.000613	CcSEcCtD
Degarelix—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000542	0.000612	CcSEcCtD
Degarelix—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000538	0.000607	CcSEcCtD
Degarelix—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00053	0.000598	CcSEcCtD
Degarelix—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000528	0.000596	CcSEcCtD
Degarelix—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000528	0.000596	CcSEcCtD
Degarelix—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000521	0.000588	CcSEcCtD
Degarelix—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000515	0.000581	CcSEcCtD
Degarelix—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00051	0.000576	CcSEcCtD
Degarelix—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00051	0.000575	CcSEcCtD
Degarelix—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.00057	CcSEcCtD
Degarelix—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.00057	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000505	0.00443	CbGpPWpGaD
Degarelix—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000504	0.000568	CcSEcCtD
Degarelix—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000502	0.000567	CcSEcCtD
Degarelix—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000491	0.000554	CcSEcCtD
Degarelix—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000487	0.000549	CcSEcCtD
Degarelix—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.000549	CcSEcCtD
Degarelix—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.000549	CcSEcCtD
Degarelix—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000483	0.000546	CcSEcCtD
Degarelix—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000476	0.000537	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000475	0.00417	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000475	0.00417	CbGpPWpGaD
Degarelix—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000468	0.000528	CcSEcCtD
Degarelix—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000464	0.000524	CcSEcCtD
Degarelix—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000464	0.000523	CcSEcCtD
Degarelix—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000461	0.00052	CcSEcCtD
Degarelix—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000458	0.000517	CcSEcCtD
Degarelix—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000437	0.000493	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000361	0.00317	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000356	0.00312	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00035	0.00307	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000325	0.00285	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000318	0.00279	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000188	0.00165	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000187	0.00164	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.00011	0.00097	CbGpPWpGaD
